Cathie Wood’s ARK Invest Buys Over 150,000 Shares of This COVID-19 Vaccine Supplier
One of Cathie Wood's ARK Invest funds bought over 150,000 shares of Pfizer on August 18.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 150,000 shares of Pfizer Inc. (NYSE: PFE | PFE Price Prediction) on Wednesday, as the price of this fund was flat in Wednesday’s session. It is still up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 158,788 shares of Pfizer. At Wednesday’s closing price, this would have valued this purchase at roughly $7.8 million. This is only a small fraction of the total holdings. The fund is up 31% over the past 52 weeks.
Check out all the ARK Invest buys for Wednesday:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | PATH | UiPath | 80,400 |
| ARKF | PLTR | Palantir Technologies | 93,189 |
| ARKF | Z | Zillow | 21,507 |
| ARKG | RPTX | Repare Therapeutics | 3,791 |
| ARKG | SURF | Surface Oncology | 41,741 |
| ARKG | QSI | Quantum-Si | 130,116 |
| ARKG | VCYT | Veracyte | 33,477 |
| ARKG | PFE | Pfizer | 158,788 |
| ARKG | NVTA | Invitae | 242,234 |
| ARKG | ZY | Zymergen | 34,547 |
| ARKG | MASS | 908 Devices | 21,511 |
| ARKG | EXAS | Exact Sciences | 134,729 |
| ARKG | DYNS | Dynamics Special Purpose | 92,700 |
| ARKG | CRSP | CRISPR Therapeutics | 19,000 |
| ARKG | SMFR | Sema4 | 307,823 |
| ARKK | TSP | TuSimple | 130,152 |
| ARKK | SRNG | Soaring Eagle Acquisition | 180,000 |
| ARKK | SGFY | Signify Health | 120,721 |
| ARKK | NVTA | Invitae | 118,534 |
| ARKK | NTLA | Intellia Therapeutics | 67,593 |
| ARKK | CRSP | CRISPR Therapeutics | 18,436 |
| ARKK | BEAM | Beam Therapeutics | 4,174 |
| ARKK | FATE | Fate Therapeutics | 102 |
| ARKK | EDIT | Editas Medicine | 17,973 |
| ARKQ | AVAV | Aerovironment | 19,814 |
| ARKQ | BLDE | Blade Air Mobility | 14,731 |
| ARKQ | KMTUY | Komatsu | 103,400 |
| ARKQ | MKFG | Markforged | 102,260 |
| ARKQ | TSP | TuSimple | 90,773 |
| ARKW | CND | Concord Acquisition | 20,000 |
| ARKW | GENI | Genius Sports | 241,657 |
| ARKW | KVSB | Khosla Venture Acquisition II | 9,053 |
| ARKW | LPSN | LivePerson | 46,116 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=937284][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
